BIO ANLAYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CAPECITABINE AND DOCETAXEL AND ITS APPLICATION TO PHARMACOKINETIC STUDIES USING LC-MS/MS

SHAIK NAGUL SHAREEF; K. V. PADMAVATHI; S. ARAVIND; MANNAM SUBBARAO

doi:10.22159/ijap.2024v16i4.50125

Authors

SHAIK NAGUL SHAREEF Department of Chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, A.P, India https://orcid.org/0000-0001-7962-4710
K. V. PADMAVATHI Department of Chemistry, T.R.R. Govt. Degree College, Kandukur, SPSR Nellore District, India
S. ARAVIND Department of Chemistry, University College of Science, Saifabad, Osmania University, Hyderabad-500004, Telangana State, India
MANNAM SUBBARAO Department of Chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, A.P, India

DOI:

https://doi.org/10.22159/ijap.2024v16i4.50125

Keywords:

Capecitabine, Docetaxel, LC-MS/MS, USFDA guidelines, Rat plasma

Abstract

Objective: An easy, quick, precise, active and reproducible Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) technique was developed for the bio analytical method of Capecitabine and Docetaxel using D₉-Capecitabine and D₉-Docetaxel as Internal Standard (IS).

Methods: This article summarizes the recent progress on bioanalytical LC-MS/MS methods using Symmetry C₁₈ column (150x4.6 mm, 3.5µ) and organic mobile phase of 0.1% formic acid and Acetonitrile in 80:20 v/v.

Results: Analysis was carried out within 5 minutes over a good linear concentration range from 37.5ng/mL to 300ng/mL (r²= 0.9999 ± 0.008) for Capecitabine and 10ng/mL to 80ng/mL (r²=0.9993± 0.005) for Docetaxel. Accuracy, precision, recovery, matrix effect and stability results were found to be within the suitable limits.

Conclusion: The application denotes all the parameters of system suitability, specificity, linearity and accuracy are in good agreement with United States Food and Drug Administration (USFDA) guidelines and applied effectively for the investigation of pharmacokinetic studies in rat.

Downloads

Download data is not yet available.

References

Carretero-Barrio I, Santón A, Caniego Casas T, López Miranda E, et al. Cytological and molecular characterization of secretory breast carcinoma. Diagn Cytopathol 2022; 50: E174–80. doi:10.1002/dc.24945

Owens DK, Davidson KW, Krist AH, Barry MJ, et al. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2019; 322: 857–67. doi:10.1001/jama.2019.11885

Juul JS, Hornung N, Andersen B, Laurberg S, Olesen F, Vedsted P. The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer. Br J Cancer 2018; 119: 471–9. doi:10.1038/s41416-018-0178-7

Qaseem A, Crandall CJ, Mustafa RA, Hicks LA, Wilt TJ, Forciea MA, et al. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. Ann Intern Med 2019; 171: 643–54. doi:10.7326/M19-0642

Matera C, Gomila AM, Camarero N, Libergoli M, Soler C, Gorostiza P. Photoswitchable Antimetabolite for Targeted Photoactivated Chemotherapy. J Am Chem Soc 2018; 140: 15764–73. doi:10.1021/jacs.8b08249

Kareem AA, Farhood QK, Alhammami HA. The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium. Clin Ophthalmol 2012; 6: 1849–54. doi:10.2147/OPTH.S38388

Tammela Tuomas, Sage Julien. Investigating Tumor Heterogeneity in Mouse Models. Annu Rev Cancer Biol 2020; 4: 99–119. doi:10.1146/annurev-cancerbio-030419-033413

Palluk Sebastian, Arlow Daniel H, et al. De novo DNA synthesis using polymerase-nucleotide conjugates. Nature Biotechnology 2018; 36: 645–50. doi:10.1038/nbt.4173

Perkel Jeffrey M. The race for enzymatic DNA synthesis heats up. Nature 2019; 566: 565.

Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007; 67: 1343–57. doi:10.2165/00003495-200767090-00007

Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremikwu MM, Critchley JA. Hand-washing promotion for preventing diarrhoea. Cochrane Database Syst Rev 2021; 12: CD004265. doi:10.1002/14651858.CD004265.pub4

Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res 2015; 13: 306–12. doi:10.5217/ir.2015.13.4.306

Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847–59. doi:10.1056/NEJMra1208626

Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. The Journal of Trauma 2003; 54: 1127–30. doi:10.1097/01.TA.0000069184.82147.06

May JR, Dolen WK. Management of Allergic Rhinitis: A Review for the Community Pharmacist. Clin Ther 2017; 39: 2410–9. doi:10.1016/j.clinthera.2017.10.006

Simpson S, Rutland P, Rutland CS. Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review. Vet Sci 2017; 4: 19. doi:10.3390/vetsci4010019

Bakalakos Athanasios, Ritsatos Konstantinos, Anastasakis Aris. Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view. Hellenic Journal of Cardiology 2018; 59: 254–61. doi:10.1016/j.hjc.2018.05.008

Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther 2013; 94: 640–5. doi:10.1038/clpt.2013.172

Chow LQ. Head and Neck Cancer. N Engl J Med 2020; 382: 60–72. doi:10.1056/nejmra1715715

Aupérin A. Epidemiology of head and neck cancers: an update. Curr Opin Oncol 2020; 32: 178–86. doi:10.1097/CCO.0000000000000629

Kodach LL, Peppelenbosch MP. Targeting the Myeloid-Derived Suppressor Cell Compartment for Inducing Responsiveness to Immune Checkpoint Blockade Is Best Limited to Specific Subtypes of Gastric Cancers. Gastroenterology 2021; 161: 727. doi:10.1053/j.gastro.2021.03.047

Nasser Nicola J, Gorenberg Miguel, Agbarya Abed. First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals 2020; 13: 373. doi:10.3390/ph13110373

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 2016; 375: 1823–33. doi:10.1056/NEJMoa1606774

Shiber JR, Santana J. Dyspnea. Med Clin North Am 2006; 90: 453–79. doi:10.1016/j.mcna.2005.11.006

Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol 2014; 20: 12908–33. doi:10.3748/wjg.v20.i36.12908

Zhao B, Meka DP, Scharrenberg R, König T, et al. Microtubules Modulate F-actin Dynamics during Neuronal Polarization. Scientific Reports 2017; 7: 9583. doi:10.1038/s41598-017-09832-8

Janke C, Bulinski JC. Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nature Reviews Molecular Cell Biology 2011; 12: 773–86. doi:10.1038/nrm3227

Potturi Ramadevi, Kantipudi Rambabu. Bio analytical method development and validation for Ezetimibe and Pitavastain and its applications to pharmacokinetic studies in Rat plasma by using LCMS/MS. Int J Res Pharm Sci 2020; 11: 7854-62.

Asha Eluru, Surendra Babu K. Bio analytical method development and validation for Aplidine in rat plasma and their pharmacokinetic studies by LCMS. WJPPS 2019; 8: 1201-9.

D. Ramchandran, Anita Kethipalli, Mannam Krishnamurthy. Bio analytical method development and validation of Daunorubicin and Cytrarabine in rat plasma by LC-MS/MS and its application in pharmacokinetic studies. J Pharm Sci & Res 2020; 12: 381-6.

Mukta D. Naykode, Durgacharan A. Bhagwat, Swapnil D. Jadhav, Harinath N, et al. Analytical and bio analytical method for quantification of pure azilsartan, not its salt by RP-HPLC. Research J Pharm and Tech 2017; 10: 708-14.

Mayanka Singh, Manoj Charde, Rajesh Shukla, Rita M.C. Determination of calcipotriene in calcipotriene cream 0.05% w/w by RP-HPLC method development and validation. Research J Pharm and Tech 2011; 4: 1219-23.

Malathi S, Arunadevi N. Development and validation of stability-indicating simultaneous estimation of metformin and alogliptin in tablets by high-performance thin layer chromatography. Int J Pharm Pharm Sci 2020; 12: 68-73.

Senthil Rajan D, Muruganathan G, Shivkumar K, Ganesh T. Development and validation of hplc method for simultaneous quantification of vasicine, glycyrrhizin and piperine in poly herbal cough syrup. Int J Curr Pharm Res 2020; 12: 15-9.

Palani Shanmugasundaram, Kamarapu S.K. RP-HPLC method for the simultaneous estimation and validation of amlodipine besylate and atenolol in bulk and tablet dosage form in biorelevant dissolution medium (Fassif). Research J Pharm and Tech 2017; 10: 3379-85.

Gomathy S, Narenderan S.T, Meyyanathan S.N, Gowramma B. Development and validation of hplc method for the simultaneous estimation of apigenin and luteolin in commercial formulation. J Crit Rev 2020; 7: 4785-90.

Ashutosh kumar S, Manidipa Debnath, Dr. Seshagiri Rao J.V.L.N, Dr. Gowri Sankar D. Development and validation of a sensitive RP-HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form by using PDA detector in Gradient mode. Research J Pharm and Tech 2016; 9: 549-54.

Malak Y, Al-Bathish A. A, Gazy M. K. El-Jamal. RP-HPLC and chemometric methods for the determination of two anti-diabetic mixtures;metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci 2020; 12: 83-94.

Gadhvi M.P, Bhandari A, Suhagia B.N, Desai U.H. Development and validation of RP-HPLC method for simultaneous estimation of atazanavir and ritonavir in their combined tablet dosage form. Research J Pharm and Tech 2013; 6: 200-3.

Koya Prabhakara Rao, Namburi L A Amara babu, Kalyani Koganti, Babji Palakeeti, Koduri S. V. Srinivas. Related substances method development and validation of an LC-MS/MS method for the quantification of Selexipag and its related impurities in rat plasma and its application to pharmacokinetic studies. SN applied sciences 2021; 3: 321.

Siva Madhu Chaitanya, Srinath Nissankararao, Satya Lakshmi Gandham. A sort of validated Bio analytical method developed for the estimation of Etoposide and Cisplatin in rat plasma by using two different advanced liquid chromatographic techniques like HPLC and UPLC and its application in bio equivalence studies. Int J Res Pharma Sci 2021; 12: 708-17.

Naveen V M K, Veeraswami B, Srinivasa Rao G. High response bio analytical validation approach of Nadolol and Bendroflumethiazide by LC-MS/MS on rat plasma. Int J Res Pharma Sci 2020; 11: 2272-9.

Gowri Kusuma Kumari, Rambabu Kantipudi. Bio analytical method development and validation for Avapritinib in rat plasma by LC-MS/MS. J Pharm Sci & Res 2021; 13: 134-7.

Hemanth Kumar A K, Sudha V, Vijayakumar A, Padmapriyadarsini C. Simultaneous method for the estimation of Bidaquiline and Delamanid in human plasma using high performance liquid chromatography. Int J Pharm Pharm Sci 2021; 13: 36-40.

Hasanah Y I F, Harahap Y, Suryadi H. Development and validation method of Cyclophosphamide and 4-hydroxy cyclophosphamide with 4-hydroxy cyclophosphamide-D4 as internal standard in dried blood spots using UPLC-MS/MS. Int J App Pharm 2021; 13: 148-52.

Nagaraju Pappula, Balaji Kodali, Peda Varma Datla. Selective and rapid determination of Tadalafil and Finasteride using solid phase extraction by high performance liquid chromatography and tandem mass spectrometry. J Pharm Biomed Anal 2018; 152: 215-23. doi: 10.1016/j.jpba.2018.01.020.

Indira Priyadarshini, Akila Devi D. Development and validation of an LC-MS/MS method for the determination of Tenofovir and Emtricitabine. Int J App Pharm 2024; 16: 116-23.

Triswanto Sentat, Henny Lucida, Widyati Widyati, Hansen Nasif, et al. Development and validation of a bio analytical method for the therapeutic drug monitoring of Amikacin in human plasma using Ultra performance liquid chromatography tandem mass spectrometry. Int J App Pharm 2024; 16 (Special issue 1): 140-4.